These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. New treatments targeting the basic defects in cystic fibrosis. Fajac I; Wainwright CE Presse Med; 2017 Jun; 46(6 Pt 2):e165-e175. PubMed ID: 28554723 [TBL] [Abstract][Full Text] [Related]
28. Increased expression of cystic fibrosis transmembrane conductance regulator in rat liver after common bile duct ligation. Shen H; Fan Y; Yang X; Burczynski FJ; Li P; Gong Y J Cell Physiol; 2005 Jun; 203(3):599-603. PubMed ID: 15605366 [TBL] [Abstract][Full Text] [Related]
29. Loss of cftr function leads to pancreatic destruction in larval zebrafish. Navis A; Bagnat M Dev Biol; 2015 Mar; 399(2):237-48. PubMed ID: 25592226 [TBL] [Abstract][Full Text] [Related]
30. Cystic fibrosis mouse model-dependent intestinal structure and gut microbiome. Bazett M; Honeyman L; Stefanov AN; Pope CE; Hoffman LR; Haston CK Mamm Genome; 2015 Jun; 26(5-6):222-34. PubMed ID: 25721416 [TBL] [Abstract][Full Text] [Related]
31. Cystic Fibrosis-related Liver Disease: The Next Challenge. Baker RD; Baker SS J Pediatr Gastroenterol Nutr; 2020 Oct; 71(4):421-422. PubMed ID: 32740535 [TBL] [Abstract][Full Text] [Related]
32. Cellular heterogeneity of CFTR expression and function in the lung: implications for gene therapy of cystic fibrosis. Jiang Q; Engelhardt JF Eur J Hum Genet; 1998 Jan; 6(1):12-31. PubMed ID: 9781011 [TBL] [Abstract][Full Text] [Related]
33. Understanding how cystic fibrosis mutations disrupt CFTR function: from single molecules to animal models. Wang Y; Wrennall JA; Cai Z; Li H; Sheppard DN Int J Biochem Cell Biol; 2014 Jul; 52():47-57. PubMed ID: 24727426 [TBL] [Abstract][Full Text] [Related]
35. Diagnosis, follow-up and treatment of cystic fibrosis-related liver disease. van de Peppel IP; Bertolini A; Jonker JW; Bodewes FAJA; Verkade HJ Curr Opin Pulm Med; 2017 Nov; 23(6):562-569. PubMed ID: 28837442 [TBL] [Abstract][Full Text] [Related]
36. Zhou ZP; Yang LL; Cao H; Chen ZR; Zhang Y; Wen XY; Hu J Hum Gene Ther; 2019 Sep; 30(9):1101-1116. PubMed ID: 31099266 [TBL] [Abstract][Full Text] [Related]
37. Liver and biliary problems in cystic fibrosis. Colombo C; Battezzati PM; Strazzabosco M; Podda M Semin Liver Dis; 1998; 18(3):227-35. PubMed ID: 9773423 [TBL] [Abstract][Full Text] [Related]
38. Management of endocrine disease: Cystic fibrosis-related diabetes: novel pathogenic insights opening new therapeutic avenues. Barrio R Eur J Endocrinol; 2015 Apr; 172(4):R131-41. PubMed ID: 25336504 [TBL] [Abstract][Full Text] [Related]
39. Gastrointestinal, Pancreatic, and Hepatobiliary Manifestations of Cystic Fibrosis. Sathe MN; Freeman AJ Pediatr Clin North Am; 2016 Aug; 63(4):679-98. PubMed ID: 27469182 [TBL] [Abstract][Full Text] [Related]
40. Gene therapy for cystic fibrosis using E1-deleted adenovirus: a phase I trial in the nasal cavity. The University of North Carolina at Chapel Hill. Boucher RC; Knowles MR; Johnson LG; Olsen JC; Pickles R; Wilson JM; Engelhardt J; Yang Y; Grossman M Hum Gene Ther; 1994 May; 5(5):615-39. PubMed ID: 7519885 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]